ARTICLE | Company News
United Therapeutics in-licenses IW001
February 11, 2010 1:21 AM UTC
ImmuneWorks Inc. (Indianapolis, Ind.) granted United Therapeutics Corp. (NASDAQ:UTHR) exclusive, worldwide rights to develop and commercialize IW001. The purified Type V bovine collagen oral solution ...